Deep Wise
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Deep Wise - overview
Established
2017
Location
Beijing, -, China
Primary Industry
Healthcare
About
Established in 2017 and based in Beijing, China, Deep Wise operates as a medical technology company that provides medical service institutions with internet medical solutions based on artificial intelligence technology. The company’s chairman, Lei Ming, obtained a master’s degree in computer science from Peking University. He is the founder of Kuwo Music and the director of Peking University’s Artificial Intelligence Innovation Center. The company’s CEO, Qiao Xin, graduated from Zhejiang University, majoring in biomedical engineering.
He was the former Vice President of Siemens (China) Medical Business Unit Greater China. The company is headquartered in Beijing and has branches in Shanghai and Hangzhou. In January 2025, it raised venture funding for approximately CNY 500 million. The company's main products include artificial intelligence-assisted diagnosis systems, cloud imaging systems, and scientific research platforms.
The diagnosis system and cloud imaging system mainly provide doctors with clinical diagnosis suggestions and realize the exchange of medical data. They are currently used in early cancer screening and children's growth and development evaluation. The scientific research platform can simplify the complex process of imagingomics scientific research through machine learning technology. It uses a variety of classification models to automatically find the best combination for result analysis.
Deep Wise generates revenue by providing all-inclusive AI - based digital medical services, such as AI - assisted diagnosis and patient service solutions, to numerous medical institutions. The company will use the venture funding to build AI-digitalized healthcare products and solutions.
Current Investors
DHVC, Kinzon Capital, FengHe Fund Management
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT
Website
www.deepwise.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.